(Q37738730)

22 August 2017

1 reference

title

Current concepts about chromium supplementation in type 2 diabetes and insulin resistance (English)

1 reference

22 August 2017

0 references

1 reference

1 reference

1 reference

2

William T Cefalu

1 reference

22 August 2017

Zhong Q Wang

1

1 reference

22 August 2017

publication date

1 April 2010

1 reference

22 August 2017

published in

Current diabetes report

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

145-151

1 reference

Nutritional factors influencing the glucose/insulin system: chromium

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0097-3

Mechanisms of chromium action: low-molecular-weight chromium-binding substance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0097-3

Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0097-3

Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0097-3

Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

12 December 2020

Insulin resistance and the pathogenesis of non-insulin dependent diabetes mellitus: cellular and molecular mechanisms.

1 reference

12 December 2020

Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance

1 reference

12 December 2020

Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes.

1 reference

12 December 2020

Chromium deficiency during total parenteral nutrition

1 reference

12 December 2020

Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance

1 reference

12 December 2020

Chromium oligopeptide activates insulin receptor tyrosine kinase activity

1 reference

12 December 2020

Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance: response to Gunton et al.

1 reference

12 December 2020

Cellular chromium enhances activation of insulin receptor kinase

1 reference

12 December 2020

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study

1 reference

12 December 2020

Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice

1 reference

12 December 2020

Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats.

1 reference

12 December 2020

Chromium and vanadate combination increases insulin-induced glucose uptake by 3T3-L1 adipocytes

1 reference

12 December 2020

Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes

1 reference

12 December 2020

Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions

1 reference

12 December 2020

Role of chromium in human health and in diabetes

1 reference

12 December 2020

Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation

1 reference

12 December 2020

Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults

1 reference

12 December 2020

Chromium in metabolic and cardiovascular disease

1 reference

12 December 2020

Obesity, Metabolic Syndrome, and Cardiovascular Disease

1 reference

12 December 2020

A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP).

1 reference

12 December 2020

Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice

1 reference

12 December 2020

Elucidating a biological role for chromium at a molecular level

1 reference

12 December 2020

Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats

1 reference

12 December 2020

Clinical studies on chromium picolinate supplementation in diabetes mellitus--a review

1 reference

12 December 2020

Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism

1 reference

12 December 2020

Chromium infusion reverses extreme insulin resistance in a cardiothoracic ICU patient

1 reference

12 December 2020

The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality

1 reference

12 December 2020

Pharmacotherapy for the treatment of patients with type 2 diabetes mellitus: rationale and specific agents

1 reference

12 December 2020

Insulin receptor substrate proteins and diabetes

1 reference

12 December 2020

1 reference

12 December 2020

A glucose tolerance factor and its differentiation from factor 3

1 reference

12 December 2020

Chromium Deficiency in Rats: a Syndrome Simulating Diabetes Mellitus with Retarded Growth

1 reference

12 December 2020

Niacin-bound chromium enhances myocardial protection from ischemia-reperfusion injury.

1 reference

12 December 2020

Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations

1 reference

12 December 2020

Chromium (D-phenylalanine)3 supplementation alters glucose disposal, insulin signaling, and glucose transporter-4 membrane translocation in insulin-resistant mice

1 reference

12 December 2020

Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials

1 reference

12 December 2020

Chromium picolinate for insulin resistance in subjects with HIV disease: a pilot study

1 reference

12 December 2020

Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats

1 reference

12 December 2020

Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes

1 reference

12 December 2020

Chromium intake, absorption and excretion of subjects consuming self-selected diets

1 reference

12 December 2020

Dietary supplement use by American women: challenges in assessing patterns of use, motives and costs

1 reference

12 December 2020

Chromium update: examining recent literature 1997-1998.

1 reference

12 December 2020

The biochemistry of chromium

1 reference

12 December 2020

Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome

1 reference

12 December 2020

Chromium in the prevention and control of diabetes

1 reference

12 December 2020

Effect of chromium and zinc on insulin signaling in skeletal muscle cells

1 reference

12 December 2020

Composition and biological activity of chromium-pyridine carboxylate complexes

1 reference

12 December 2020

10.1007/S11892-010-0097-3

Identifiers

DOI

1 reference

22 August 2017

1 reference